Page 2 - Mark Neumann News Today : Breaking News, Live Updates & Top Stories | Vimarsana

MADISON, Wis. -- The leader of Wisconsin's Department of Revenue will step down next month, Gov. Tony Evers announced Thursday.

Intra-Cellular Therapies, Inc. (NASDAQ:ITCI) Q4 2023 Earnings Call Transcript February 22, 2024 Intra-Cellular Therapies, Inc. beats earnings expectations. Reported EPS is $-0.3, expectations were $-0.44. Intra-Cellular Therapies, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good morning, ladies and […]

Intra-Cellular Therapies, Inc. beats earnings expectations. Reported EPS is $-0.3, expectations were $-0.44. Intra-Cellular Therapies, Inc.

Intra-Cellular Therapies, Inc. (NASDAQ:ITCI – Get Free Report) has been given a consensus recommendation of “Moderate Buy” by the eleven analysts that are presently covering the company, MarketBeat.com reports. One research analyst has rated the stock with a hold rating and ten have given a buy rating to the company. The average 1-year target price […]

AdvisorShares Investments LLC grew its holdings in Intra-Cellular Therapies, Inc. (NASDAQ:ITCI – Free Report) by 22.4% in the third quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 5,772 shares of the biopharmaceutical company’s stock after buying an additional 1,057 shares during the quarter. AdvisorShares […]